Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-25-087549

Interim CEO & General Counsel gave up 22,127 shares (to pay taxes)

  • Interim CEO & General Counsel acquired 52,086 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Vogt Frederick G Interim CEO & General Counsel 2025-09-02 Option exercise +52,086 456,690 D
Vogt Frederick G Interim CEO & General Counsel 2025-09-02 Shares withheld for taxes −22,127 $2.19 $48,458 434,563 D
Derivatives
Vogt Frederick G Interim CEO & General Counsel 2025-09-02 Option exercise · Restricted Stock Units −10,417 20,385 D
Vogt Frederick G Interim CEO & General Counsel 2025-09-02 Option exercise · Restricted Stock Units −41,669 250,013 D
Loading xslF345X05/tm2525186-4_4seq1.xml…